Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients

<i>Background and Objectives</i>: One of the most frequently mutated oncogenes in cancer belongs to the Ras family of proto-oncogenes, which encode distinct key signaling events. RAS gain-of-function mutations are present in ~30% of all human cancers, with KRAS being the most frequently...

Full description

Bibliographic Details
Main Authors: Veronica Aran, Mariano Zalis, Tatiane Montella, Carlos Augusto Moreira de Sousa, Bruno L. Ferrari, Carlos Gil Ferreira
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/10/1039